Third Biennial Symposium on Biology, Diagnosis and Treatment of Lymphomas
The Abramson Cancer Center of the University of Pennsylvania
Last Modified: August 15, 2005
Conference Dates: Friday, October 14, 2005
Conference Location: Marriott West, West Conshohocken, PA
Sponsoring Group: Abramson Cancer Center of the University of Pennsylvania
Conference Brochure: Download PDF version of conference brochure.
Topics Covered: Non-Hodgkins, Hodgkins, Prognostic Markers, New Targeted Therapies
Conference Objectives: At the completion of this conference, participants should be able to:
- Discuss the current classification of lymphomas as well as the controversies in diagnosis and their impact on management;
- Gain new insight into pathogenesis of lymphomas;
- Appreciate the growing role of understanding the basic mechanisms of the disease in diagnosis and treatment of lymphomas;
- Critically assess novel diagnostic and therapeutic approaches to lymphomas
Who Should Attend: Clinical Oncologists, Pathologists, Hematopathologists, Oncology Nurses and other health care professional involved in the treatment of patients with lymphoma
- Welcome and Introduction: John Glick
- Classification of lymphomas: Dale Frank
- Biology of non-Hodgkin’s lymphomas: diagnostic and therapeutic implications: Mariusz A. Wasik
- Biology of Hodgkin lymphoma: Harald Stein (Free Univ. Berlin) 9:40- 9:55 Questions and Answers
- Proteomic analysis of aberrant cell signaling in lymphomas: Kojo Elenitoba-Johnson (Univ. of Utah)
- Prognostic markers in small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL): Adam Bagg
- siRNA expression profile of SLL/CLL: Carlo Croce (Ohio State)
- Glucose metabolism by lymphoma cells: diagnostic and therapeutic implications: Rebecca Ellstrom (Univ. of Michigan)
- Antibody-based therapy of lymphomas: John Leonard (Weill/Cornell)
- Histone deactehylase inhibitors in treatment of lymphomas: Ellen Kim
- Targeted therapies for SLL/CLL: John Byrd (Ohio State)
- Targeted therapies for non SLL/CLL small B-cell lymphomas: Stephen Schuster
- New therapeutic agents for aggressive B-cell lymphoma: Sunita Nasta
- Closing remarks: Mariusz Wasik/Stephen Schuster
Registration Information: For more information, or to request a brochure, please contact Mary Graham at 215-662-7328 or email@example.com.
Conference Fees: $175.00 physician, $95.00 nurses and other health care professionals, No fee for faculty, staff, fellows & students of the University of Pennsylvania
All fields are required.
Make checks payable to: Trustees, University of Pennsylvania. Mail payment and registration to:
Abramson Cancer Center of the University of Pennsylvania
3400 Spruce St. - 16 Penn Tower
Philadelphia, PA 19104-4283
P: 215-662-7328 • F: 215-614-1854
Continuing Education: Yes. The University of Pennsylvania School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
I Wish You Knew
How cancer patients have changed my life
Blogs and Web Chats
OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.
Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!